Rousseau Raphael

Track

Insider profile

Performance

Overall performance
0.8
Performance over holding periods
0.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rousseau Raphael's trades of Gritstone Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
217.33
Quantity 10,703 +47.6%
Value US$4,141,699
Transaction date
Planned sale
Price
232.51
Quantity 87,955 +11.4%
Value US$4,228,114
Transaction date
Planned sale
Price
135.45
Quantity 64,860 +25.4%
Value US$3,877,305
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-03 2021-05-27
S Sale
10,703 +47.6%
217.33
US$4,141,699 		10,703 +47.6% 217.33 US$4,141,699
2021-01-21 2021-01-20
PlS Planned sale
87,955 +11.4%
232.51
US$4,228,114 		87,955 +11.4% 232.51 US$4,228,114
2021-01-21 2021-01-19
PlS Planned sale
64,860 +25.4%
135.45
US$3,877,305 		64,860 +25.4% 135.45 US$3,877,305